2014
DOI: 10.1016/j.jsbmb.2013.10.009
|View full text |Cite
|
Sign up to set email alerts
|

The Women's Health Initiative trial and related studies: 10 years later: A clinician's view

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
79
0
4

Year Published

2014
2014
2020
2020

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 106 publications
(95 citation statements)
references
References 48 publications
1
79
0
4
Order By: Relevance
“…Also, earlier clinical observations suggested that climacteric women receiving E2 containing menopausal hormone therapy (MHT) to reduce menopausal symptoms have lower rates of CVD, supporting the vascular benefits of E2 (Reslan and Khalil, 2012;Gurney et al, 2014). The beneficial vascular effects of E2 have been ascribed to modification of circulating lipoproteins, inhibition of the vascular accumulation of collagen, and vasodilator effects on the endothelium and vascular smooth muscle (VSM) (Mendelsohn, 2002;Khalil, 2013).…”
Section: Introductionmentioning
confidence: 98%
See 2 more Smart Citations
“…Also, earlier clinical observations suggested that climacteric women receiving E2 containing menopausal hormone therapy (MHT) to reduce menopausal symptoms have lower rates of CVD, supporting the vascular benefits of E2 (Reslan and Khalil, 2012;Gurney et al, 2014). The beneficial vascular effects of E2 have been ascribed to modification of circulating lipoproteins, inhibition of the vascular accumulation of collagen, and vasodilator effects on the endothelium and vascular smooth muscle (VSM) (Mendelsohn, 2002;Khalil, 2013).…”
Section: Introductionmentioning
confidence: 98%
“…Despite evidence from earlier clinical observations and experimental studies, randomized clinical trials in postmenopausal women with or without CVD have shown no vascular benefits from MHT (Reslan and Khalil, 2012;Gurney et al, 2014). Several factors could have contributed to the lack of vascular benefits of MHT, including preexisting CVD, the subject's age, and age-related changes in estrogen receptor (ER) amount, distribution, integrity, and post-ER signaling mechanisms (Reslan and Khalil, 2012;Gurney et al, 2014).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…benefits for the fetus and no increased risk of maternal death.' 3 Another reference misquoted by Ms Cohain 4 reports that, contrary to her assertion that low risk pregnancies are uncomplicated, a high percentage of low risk pregnancies had unexpected complications. Recommendations to support home births in 'low risk' pregnancies are therefore questionable.…”
Section: Sirmentioning
confidence: 99%
“…Recommendations to support home births in 'low risk' pregnancies are therefore questionable. 4 Ms Cohain claims that cord prolapse is 'the only event with better outcomes in a hospital'. This is false.…”
Section: Sirmentioning
confidence: 99%